Is This Popular Breast Cancer Drug Causing Permanent Hair Loss?

Multiple lawsuits have been filed against Sanofi-Aventis, the pharmaceutical company behind the breast cancer drug Taxotere. According to the lawsuits, Sanofi-Aventis failed to warn patients they could permanently lose their hair by taking the chemotherapy drug. The lawsuits also claim Sanofi-Aventis knew Taxotere could cause permanent hair loss in 2005, but did not change the labeling until January of 2016 to warn of the risks.

What Are Possible Long-Term Effects of Permanent Hair Loss Caused by Taxotere?

Women who took Taxotere and lost their hair are at risk to experience  long-term psychological effects. A study published in the British Medical Journal claims women who experience permanent hair loss suffer an identity crisis and damage to their self-esteem.

Women hurt by these side effects are also more likely to experience problems in their personal and professional lives. According to the British Medical Journal study, 40 percent of women with permanent hair loss suffered marital problems and another 63 percent reported a negative impact on their careers.

Several lawsuits filed against Sanofi-Aventis claim women would have chosen safer chemotherapy drugs if they had been informed of the risks of permanent hair loss. Women who have experienced permanent hair loss by taking Taxotere should contact an attorney to explore possible legal options.

The New Jersey personal injury attorneys at Keefe Law Firm will hold pharmaceutical companies accountable for concealing the dangerous side effects of prescription drugs.

Print Friendly, PDF & Email


Leave a Reply

Your email address will not be published. Required fields are marked *